The inauguration of the Allan-Robb Campus marks the completion of the construction phase of the £29 million manufacturing facility that started in 2016.
The Allan-Robb Campus is named after John Allan and Gordon Robb, two senior executives who have been key in building Quotient into a global company from its roots as a unit of the Scottish National Blood Transfusion Service supplying immunohematology reagents to the Scottish NHS.
The new facility comprises 85,000 square feet of space, compared with its previous 22,000 square feet at a close-by location.
“Along with research & development and management, the Allan-Robb Campus will house our reagent manufacturing operations and will provide further capacity to supply the reagent requirements for our MosaiQ™ system.”
Franz Walt, Interim Chief Executive Officer of Quotient
“The inauguration testifies to Quotient’s long-term commitment to the global transfusion diagnostics market, both through the on-going supply of liquid reagents and through its transformational MosaiQ™ transfusion diagnostics system that provides a comprehensive automated testing solution, thereby increasing laboratory efficiencies and improving patient outcomes.”
Paul Cowan, Founder of Quotient
The Allan-Robb Campus brings together onto one site Quotient’s Edinburgh team that had previously been spread over four locations. The new facility now also houses Quotient’s scientific research team working on developing Quotient’s products and accessing new markets. In 2017, the team secured 17 new product licence approvals from the FDA for sale in the USA. In addition, the Allan-Robb Campus will provide laboratory and office space for a team of about 50 scientists working with other group companies on the development of the MosaiQ™ system.